Therapy Areas: Oncology
Curaleaf announces clinical registrant designation from the Pennsylvania Department of Health National
24 February 2020 -

Cannabis operator Curaleaf Holdings Inc (CSE:CURA) (OTCQX:CURLF) reported on Friday the receipt of the Commonwealth's Department of Health, Office of Medical Marijuana clinical registrant status in Pennsylvania, USA.

Under the Commonwealth's medical marijuana research programme, the new clinical registrant designation allows the company to open a cultivation and processing facility as well as up to six dispensaries in Pennsylvania.

Through the clinical registrant status, the company will support research initiatives into the potential medical benefits of cannabis by providing medical cannabis, expertise and distribution to patients participating in studies.

According to Dr Rachel Levine of the Pennsylvania Department of Health, Pennsylvania remains on the forefront for clinical research on medical marijuana. The research will provide physicians with more evidence-based research to make clinical decisions for their patients suffering with cancer, PTSD and other serious medical conditions.

Login
Username:

Password: